Back to
Ameriprise Financial Inc.
RYTM
Showing 8 of 22 quarters
Position history for
Ameriprise Financial Inc.'s holdings in Rhythm Pharmaceuticals, Inc.
Yes. Ameriprise Financial holds 401,634 shares of RYTM (Rhythm Pharmaceuticals), worth $44.6M, as of its Q2 2026 13F filing. It increased the position by 17,677 shares (+4.6%) from Q1 2026. Ameriprise Financial has held RYTM since Q2 2022, across 17 quarterly 13F filings.
Current Value
$44.6M
Current Shares
401,634
Total Value Change
+$42.4M
Total Shares Change
+359,747
Quarter-by-Quarter History